Insider · CIK 0001187443
Arthur F Ryan
Files at REGN (REGENERON PHARMACEUTICALS, INC.). First filing Nov 8, 2023, latest Jul 7, 2026.
In brief
Arthur F Ryan files SEC Form 4 as director at REGN (REGENERON PHARMACEUTICALS, INC.). Since Nov 8, 2023, Arthur F Ryan has reported 0 open-market buys worth $0 and 13 open-market sells worth $1.2M, the latest filed on Jul 7, 2026.
A track record needs three past buys with six months of prices behind them; Arthur F Ryan has 0, so none is measured yet.
The newest scored trade: sold $130k of REGN on Jul 2, 2026, filed Jul 7, 2026, scored 6 (weak), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 5 sells worth $435k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
REGN: REGENERON PHARMACEUTICALS, INC.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 6Weak | REGENERON PHARMACEUTICALS, INC. | $130k 200 shares | -1% | +22% from low-19% from high | |
| 3Weak | REGENERON PHARMACEUTICALS, INC. | $71k 100 shares | -1% | +46% from low-14% from high | |
| 4Weak | REGENERON PHARMACEUTICALS, INC. | $78k 100 shares | -1% | +62% from low-4% from high | |
| 12Weak | REGENERON PHARMACEUTICALS, INC. | $79k 100 shares | -1% | +64% from low-3% from high | |
| 19Weak | REGENERON PHARMACEUTICALS, INC. | $78k 100 shares | -1% | +62% from low-4% from high | |
| 20Weak | REGENERON PHARMACEUTICALS, INC. | $99k 100 shares | -1% | +43% from low-0% from high | |
| 19Weak | REGENERON PHARMACEUTICALS, INC. | $90k 100 shares | -1% | +30% from low-9% from high | |
| 13Weak | REGENERON PHARMACEUTICALS, INC. | $96k 100 shares | -1% | +40% from low-2% from high | |
| 20Weak | REGENERON PHARMACEUTICALS, INC. | $98k 100 shares | -1% | +42% from low-1% from high | |
| 20Weak | REGENERON PHARMACEUTICALS, INC. | $95k 100 shares | -1% | +38% from low-0% from high | |
| 19Weak | REGENERON PHARMACEUTICALS, INC. | $90k 100 shares | -1% | +33% from low0% from high | |
| 19Weak | REGENERON PHARMACEUTICALS, INC. | $82k 100 shares | -1% | +20% from low-3% from high | |
| 19Weak | REGENERON PHARMACEUTICALS, INC. | $83k 100 shares | -1% | +22% from low-2% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Jul 2, 2026 | REGN Regeneron Pharmaceuticals, Inc. | 400 0.00% of outstanding | $250k | Jul 2, 2026 | $71k |
| Feb 9, 2026 | REGN Regeneron Pharmaceuticals, Inc. | 400 0.00% of outstanding | $314k | Feb 9, 2026 | none |
| Aug 1, 2024 | REGN Regeneron Pharmaceuticals, Inc. | 300 0.00% of outstanding | $324k | Aug 1, 2024 | $205k |
| May 1, 2024 | REGN Regeneron Pharmaceuticals, Inc. | 300 0.00% of outstanding | $267k | May 1, 2024 | $194k |
| Feb 1, 2024 | REGN Regeneron Pharmaceuticals Inc | 300 0.00% of outstanding | $284k | Feb 1, 2024 | $255k |
| Nov 7, 2023 | REGN Regeneron Pharmaceuticals Inc | 300 0.00% of outstanding | $249k | Nov 7, 2023 | none |
Transactions
The newest 50 of 182 rows this insider has filed.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 2, 2026 | REGN REGENERON PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -200 | $650.15 | $130k | 17,303 | Jul 7, 2026 |
| May 1, 2026 | REGN REGENERON PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -5 | $701.76 | $3,509 | 17,598 | May 4, 2026 |
| May 1, 2026 | REGN REGENERON PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -15 | $702.46 | $11k | 17,583 | May 4, 2026 |
| May 1, 2026 | REGN REGENERON PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -24 | $703.46 | $17k | 17,559 | May 4, 2026 |
| May 1, 2026 | REGN REGENERON PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -15 | $704.28 | $11k | 17,544 | May 4, 2026 |
| May 1, 2026 | REGN REGENERON PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -14 | $705.56 | $9,878 | 17,530 | May 4, 2026 |
| May 1, 2026 | REGN REGENERON PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -7 | $706.74 | $4,947 | 17,523 | May 4, 2026 |
| May 1, 2026 | REGN REGENERON PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -4 | $707.40 | $2,830 | 17,519 | May 4, 2026 |
| May 1, 2026 | REGN REGENERON PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -6 | $709.45 | $4,257 | 17,513 | May 4, 2026 |
| May 1, 2026 | REGN REGENERON PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -2 | $710.87 | $1,422 | 17,511 | May 4, 2026 |
| May 1, 2026 | REGN REGENERON PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -5 | $711.49 | $3,557 | 17,506 | May 4, 2026 |
| May 1, 2026 | REGN REGENERON PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -1 | $712.09 | $712 | 17,505 | May 4, 2026 |
| May 1, 2026 | REGN REGENERON PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -2 | $714.13 | $1,428 | 17,503 | May 4, 2026 |
| Apr 1, 2026 | REGN REGENERON PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -1 | $771.32 | $771 | 17,702 | Apr 3, 2026 |
| Apr 1, 2026 | REGN REGENERON PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -3 | $772.76 | $2,318 | 17,699 | Apr 3, 2026 |
| Apr 1, 2026 | REGN REGENERON PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -8 | $773.59 | $6,189 | 17,691 | Apr 3, 2026 |
| Apr 1, 2026 | REGN REGENERON PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -8 | $774.58 | $6,197 | 17,683 | Apr 3, 2026 |
| Apr 1, 2026 | REGN REGENERON PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -14 | $775.58 | $11k | 17,669 | Apr 3, 2026 |
| Apr 1, 2026 | REGN REGENERON PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -13 | $776.62 | $10k | 17,656 | Apr 3, 2026 |
| Apr 1, 2026 | REGN REGENERON PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -9 | $777.42 | $6,997 | 17,647 | Apr 3, 2026 |
| Apr 1, 2026 | REGN REGENERON PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -4 | $778.24 | $3,113 | 17,643 | Apr 3, 2026 |
| Apr 1, 2026 | REGN REGENERON PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -40 | $779.71 | $31k | 17,603 | Apr 3, 2026 |
| Mar 2, 2026 | REGN REGENERON PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -7 | $777.46 | $5,442 | 17,796 | Mar 3, 2026 |
| Mar 2, 2026 | REGN REGENERON PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -2 | $778.30 | $1,557 | 17,794 | Mar 3, 2026 |
| Mar 2, 2026 | REGN REGENERON PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -5 | $779.69 | $3,898 | 17,789 | Mar 3, 2026 |
| Mar 2, 2026 | REGN REGENERON PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -3 | $780.69 | $2,342 | 17,786 | Mar 3, 2026 |
| Mar 2, 2026 | REGN REGENERON PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -2 | $781.21 | $1,562 | 17,784 | Mar 3, 2026 |
| Mar 2, 2026 | REGN REGENERON PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -2 | $782.62 | $1,565 | 17,782 | Mar 3, 2026 |
| Mar 2, 2026 | REGN REGENERON PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -10 | $783.62 | $7,836 | 17,772 | Mar 3, 2026 |
| Mar 2, 2026 | REGN REGENERON PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -9 | $784.48 | $7,060 | 17,763 | Mar 3, 2026 |
| Mar 2, 2026 | REGN REGENERON PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -11 | $785.48 | $8,640 | 17,752 | Mar 3, 2026 |
| Mar 2, 2026 | REGN REGENERON PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -7 | $786.61 | $5,506 | 17,745 | Mar 3, 2026 |
| Mar 2, 2026 | REGN REGENERON PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -2 | $787.34 | $1,575 | 17,743 | Mar 3, 2026 |
| Mar 2, 2026 | REGN REGENERON PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -20 | $788.96 | $16k | 17,723 | Mar 3, 2026 |
| Mar 2, 2026 | REGN REGENERON PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -20 | $789.28 | $16k | 17,703 | Mar 3, 2026 |
| Feb 9, 2026 | REGN REGENERON PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -1 | $775.63 | $776 | 17,902 | Feb 11, 2026 |
| Feb 9, 2026 | REGN REGENERON PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -10 | $776.59 | $7,766 | 17,892 | Feb 11, 2026 |
| Feb 9, 2026 | REGN REGENERON PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -57 | $777.56 | $44k | 17,835 | Feb 11, 2026 |
| Feb 9, 2026 | REGN REGENERON PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -12 | $778.53 | $9,342 | 17,823 | Feb 11, 2026 |
| Feb 9, 2026 | REGN REGENERON PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -5 | $779.41 | $3,897 | 17,818 | Feb 11, 2026 |
| Feb 9, 2026 | REGN REGENERON PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -1 | $780.09 | $780 | 17,817 | Feb 11, 2026 |
| Feb 9, 2026 | REGN REGENERON PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -5 | $781.48 | $3,907 | 17,812 | Feb 11, 2026 |
| Feb 9, 2026 | REGN REGENERON PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -1 | $782.53 | $783 | 17,811 | Feb 11, 2026 |
| Feb 9, 2026 | REGN REGENERON PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -3 | $783.34 | $2,350 | 17,808 | Feb 11, 2026 |
| Feb 9, 2026 | REGN REGENERON PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -1 | $784.59 | $785 | 17,807 | Feb 11, 2026 |
| Feb 9, 2026 | REGN REGENERON PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -1 | $785.71 | $786 | 17,806 | Feb 11, 2026 |
| Feb 9, 2026 | REGN REGENERON PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -2 | $786.29 | $1,573 | 17,804 | Feb 11, 2026 |
| Feb 9, 2026 | REGN REGENERON PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -1 | $787.82 | $788 | 17,803 | Feb 11, 2026 |
| Jan 2, 2026 | REGN REGENERON PHARMACEUTICALS, INC. | AGrant or award Common Stock | +155 | $0.00 | $0 | 17,903 | Jan 6, 2026 |
| Jan 2, 2026 | REGN REGENERON PHARMACEUTICALS, INC. | AGrant or award Non-Qualified Stock Option (right to buy)derivative | +1,962 | $0.00 | $0 | 1,962 | Jan 6, 2026 |
Questions about Arthur F Ryan
Answered from the filings on this page, as of the latest one.
Is Arthur F Ryan buying or selling?
In the last 12 months Arthur F Ryan reported 0 open-market buys worth $0 and 5 open-market sells worth $435k on SEC Form 4; the latest was sold $130k of REGN on Jul 2, 2026. Grants, option exercises and tax withholding are not counted.
How did Arthur F Ryan's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Arthur F Ryan has 0.
Where does Arthur F Ryan file Form 4?
Arthur F Ryan has filed Form 4 at REGN (REGENERON PHARMACEUTICALS, INC.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.